LncRNA taurine upregulated gene 1 in liver disease

Z Fan, H Pan, N Qu, X Wang, L Cao, L Chen, M Liu - Clinica Chimica Acta, 2024 - Elsevier
Long non-coding RNAs (lncRNAs) are RNA sequences exceeding 200 nucleotides in length
that lack protein-coding capacity and participate in diverse biological processes in the …

Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma

W Mao, K Wang, W Zhang, S Chen, J Xie… - Journal of Experimental …, 2022 - Springer
Background The accumulating evidence confirms that long non-coding RNAs (lncRNAs)
play a critical regulatory role in the progression of renal cell carcinoma (RCC). But, the …

The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation

X Gao, H Zhang, C Zhang, M Li, X Yu, Y Sun… - Frontiers in …, 2023 - frontiersin.org
Renal cell carcinoma (RCC) is the most frequent renal malignancy in the world, and its
incidence is increasing year by year. RCC is a well-known drug resistant tumor, and the …

[HTML][HTML] Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell …

W Yang, J Zhou, Z Zhang, K Zhang, Y Xu… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Background: The current studies only indicated that long non-coding RNA (lncRNA)
APCDD1L-AS1, as a novel lncRNA, may play a role in oral squamous cell carcinoma and …

Identification and validation of cuproptosis-related LncRNA signatures in the prognosis and immunotherapy of clear cell renal cell carcinoma using machine learning

Z Bai, J Lu, A Chen, X Zheng, M Wu, Z Tan, J Xie - Biomolecules, 2022 - mdpi.com
(1) Objective: We aimed to mine cuproptosis-related LncRNAs with prognostic value and
construct a corresponding prognostic model using machine learning. External validation of …

[HTML][HTML] Comprehensive analysis to identify the RP11–478C19. 2/E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma

K Zeng, G Song, B Chen, X Gao, C Liu, J Miao… - Translational …, 2022 - Elsevier
Clear cell renal cell carcinoma (ccRCC), accounting for 70–80% of all renal cell carcinomas,
is a common malignancy. Survival rates decrease significantly in patients with advanced …

Epigenetics in advanced renal cell carcinoma: Potential new targets

J Molina-Cerrillo, M Santoni, Á Ruiz, F Massari… - Critical Reviews in …, 2022 - Elsevier
Renal cell carcinoma (RCC) is the seventh most frequently diagnosed tumor in adults in
Europe and represents approximately 2.5% of cancer deaths. In metastatic setting, clinical …

[HTML][HTML] Role of non-coding RNAs in physiological and pathological angiogenesis

N Laham-Karam, I Mushimiyimana, K Hokkanen… - Current Opinion in …, 2023 - Elsevier
Angiogenesis, the process of building new vessels, is important in physiology. In addition, it
is involved in different pathologies, including cancers, ischemia, macular degeneration and …

A novel prognostic N7-methylguanosine-related long non-coding RNA signature in clear cell renal cell carcinoma

W Luo, J Lu, X Zheng, JJ Wang, SY Qian, ZX Bai… - Scientific Reports, 2023 - nature.com
Clear cell renal cell carcinoma (ccRCC) is regulated by methylation modifications and long
noncoding RNAs (lncRNAs). However, knowledge of N7-methylguanosine (m7G)-related …

[HTML][HTML] SEMA3G, downregulated by ncRNAs, correlates with favorable prognosis and tumor immune infiltration in kidney renal clear cell carcinoma

J Yuan, G Yuan - Aging (Albany NY), 2023 - ncbi.nlm.nih.gov
Kidney renal clear cell carcinoma (KIRC), relatively aggressive subtype of renal cell
carcinoma, lacks of effective targets and promising biomarkers. Recently, although the …